However, mutations in APC and CTNNB1 constitutively activate the Wnt/β-catenin signaling pathway to drive CRC tumorigenesis, in part, by promoting nuclear β-catenin accumulation and deregulating Wnt target gene expression [3,6]. Here, APC is linked to colorectal carcinoma.